Clinical Trial Update: Oseltamivir Randomised Controlled Efficacy Trial [Phase 3]

View source ↗

Summary

Phase 3 randomized controlled trial evaluating the efficacy of oseltamivir for influenza and related respiratory infections; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Respiratory Tract Infection
• Pneumonia
• Upper Respiratory Tract Infection

Drugs mentioned

• Tamiflu (oseltamivir)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Influenza, Pneumonia | Phase 3 | Status: COMPLETED